Biodesix News

Biodesix | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 24 22:18 ET

Biodesix | 8-K: Current report

May 23 16:17 ET

Biodesix | 8-K: Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management

May 8 16:10 ET

Biodesix | DEFA14A: Others

Apr 26 16:23 ET

Biodesix | DEF 14A: Definitive information statements

Apr 26 16:20 ET

Biodesix | S-1: General form for registration of securities under the Securities Act of 1933

Apr 23 16:23 ET

Biodesix | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 17:21 ET

Biodesix | 8-K: Current report

Apr 9 16:11 ET

Biodesix | 8-K: Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights

Mar 1 06:14 ET

Biodesix | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 2 16:15 ET

Biodesix | 8-K: Current report

Dec 20, 2023 09:19 ET

Biodesix | 8-K: Biodesix Announces Third Quarter 2023 Results and Highlights

Nov 7, 2023 16:02 ET

Biodesix | 8-K: Biodesix Announces Second Quarter 2023 Results and Highlights

Aug 7, 2023 16:06 ET

Biodesix | 8-K: Current report

Jul 26, 2023 16:07 ET

Biodesix | 8-K: Current report

Jun 6, 2023 16:26 ET

Biodesix | 8-K: Current report

May 25, 2023 16:15 ET

Biodesix | 8-K: Biodesix Announces First Quarter 2023 Results and Highlights

May 11, 2023 16:19 ET

Biodesix | DEFA14A: Others

Apr 12, 2023 16:10 ET

Biodesix | DEF 14A: Definitive proxy statements

Apr 12, 2023 16:05 ET

Biodesix | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Mar 31, 2023 16:09 ET